Xontogeny (zon-TOJ-uh-nee) is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients with serious diseases. Speciﬁcally, we partner with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.

At Xontogeny, we believe that scientific founders supply the passion and determination integral to the success of their companies. While the foundation of success is good science, how that science is developed from inception to maturity serves as the critical pathway. Therefore, we focus on supporting the entrepreneur’s pursuit and optimizing the development pathway with an exceptionally talented and experienced operational team. With our team’s track record of success, entrepreneurs of affiliated companies will gain the support and guidance they need while remaining lean, virtual, and without the financial burden of supporting a full-time team.

This dynamic model has the additional benefit of supporting the goals of the founding scientists and entrepreneurs to retain more control and equity, while increasing the chance of accessing investment, and ultimately development success.

Perceptive Advisors

Xontogeny

Horizon Technology Finance is a competitor of Xontogeny, providing financial services and support to life sciences ventures and biotech companies.

Horizon Technology Finance

United BioSource is a competitor of Xontogeny, specializing in providing support and services for the advancement of novel therapeutics and technologies in the life sciences sector.

United BioSource

Phase4 Ventures is a competitor of Xontogeny, focusing on accelerating the development of new therapies and technologies in the life sciences sector.

Phase4 Ventures

Interius BioTherapeutics is a potential competitor of Xontogeny, involved in the development of novel therapeutics and technologies in the biotech sector.

Interius BioTherapeutics

Peroxitech Therapeutics is a potential competitor of Xontogeny, focused on the development of innovative therapies and technologies in the biotech sector.

Peroxitech Therapeutics

Nodexus is a potential competitor of Xontogeny, involved in the advancement of novel therapeutics and technologies in the biotech sector.

Nodexus

Xontogeny is a life sciences venture focused on accelerating the development of new therapies and technologies that address significant unmet medical needs. The company partners with academia, innovators, and biotech companies to support the advancement of novel therapeutics through preclinical development and into clinical trials.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 15, 2024 9:22 AM	6aa6bfce
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 15, 2024 9:22 AM	68b32697
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:XONTOGENY

Xontogeny